---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-009610"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T13:25:16.738041+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# InfuSystem reports record 2024 revenue of $134.9M, +7% YoY; Adj EBITDA +13% to $25.3M; guides 2025 revenue growth 8-10%

## Summary
- Q4 net revenues $33.8M (+7% YoY); net income $0.9M ($0.04 EPS) vs $0.1M prior year.
- Full year adj EBITDA $25.3M (+13%); operating cash flow $20.5M (+82%).
- Patient Services rev $80.4M (+5%), Device Solutions $54.5M (+11%) for full year.
- 2025 guidance: revenue growth 8-10%, adj EBITDA margin above 18.8%.
- Repurchased $1.2M in 2024 and ~$2.4M in Q1 2025; net debt down $5.5M to $23.3M.

## SEC filing metadata
- accession: 0001628280-25-009610
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828025009610/0001628280-25-009610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828025009610/infu-20250304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-009610
- JSON: https://secwatch.observer/filing/0001628280-25-009610.json
- Plain text: https://secwatch.observer/filing/0001628280-25-009610.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.